Moteur de recherche d’entreprises européennes

Financement de l’UE (2 994 560 €) : Alliance européenne pour la recherche clinique sur les maladies infectieuses (ECRAID) - Plan d’affaires Hor01/01/2019 Programme de recherche et d'innovation de l'UE « Horizon »

Texte

Alliance européenne pour la recherche clinique sur les maladies infectieuses (ECRAID) - Plan d’affaires

Infectious diseases (ID) pose a continuous and serious threat to global health and economies. Reducing the impact of emerging infectious diseases (EID) and antimicrobial resistance (AMR) requires long-term, sustainable, international efforts. The European consortia COMBACTE and PREPARE have the joint ambition to establish a coordinated, permanent, pan-European infrastructure for clinical research on ID (ECRAID). The mission of ECRAID is to reduce the impact of ID on individual and population health by generating rigorous evidence to improve the diagnosis, prevention and treatment of IDs, and to better respond to ID threats. In ECRAID-Plan the coordinators and co-coordinators of PREPARE and COMBACTE, together with the (co-)coordinators of 12 other highly complementary networks and infrastructures, will develop a detailed Business Plan for ECRAID, which will serve: (i) as the guiding document in the implementation of ECRAID, (ii) to inform external stakeholders (network partners, industry, funders, policy makers, regulators, users) about ECRAID and (iii) to get commitment for sufficient start-up funding to commence operations in ECRAID, allowing for a smooth transition of activities from the current funding periods of PREPARE and COMBACTE. ECRAID-Plan will be completed within 24 months, involving extensive consultation of a multisectoral stakeholder platform. ECRAID-Plan will focus on the development of the key components of the business plan, including (i) an internal analysis of strengths and weaknesses, (ii) an external analysis of relevant stakeholders and their needs, developments in the scientific, policy and other domains and opportunities and threats, (iii) the service offering and business model, (iv) operational processes and policies, (v) governance structure and (vi) an investment plan and operational budget. Cross-cutting themes include reconciliation of AMR and EID research, data sharing and interoperabilty of networks.


ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM 79 425 €
Danmarks Tekniske Universitet 71 350 €
Ecrin European Clinical Research Infrastructure Network 252 650 €
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM 146 350 €
European Research Infrastructure ON Highly Pathogenic Agents 66 925 €
Fondazione Penta ETS 152 650 €
Istituto Nazionale Per LE Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico 71 350 €
ROBERT KOCH-INSTITUT 29 425 €
The Chancellor, Masters and Scholars of the University of Oxford 202 650 €
Umea Universitet 66 925 €
UNIVERSITAIR MEDISCH CENTRUM UTRECHT 865 235 €
Universite d'AIX Marseille 150 775 €
Universiteit Antwerpen 838 850 €

https://cordis.europa.eu/project/id/825715

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.